Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVT-01 single dose in mild asthma patients challenged with inhaled TNF-alpha
2006-004191-13Phase 2Terminated
- Sponsor
- Avontec
- Start
- Oct 2006
- Modality
- Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, MicroRNA (miRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Antisense Oligonucleotides (ASOs) → Long RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in asthma comparing AVT-01 10 mg with Placebo (2 arms). Started Oct 2006; status: terminated.
02
Drugs
AVT-01
03
Conditions
asthma
Beyond the preview
Go deeper on 2006-004191-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004191-13.